Alexander Chapman

Senior Vice President, Investor Relations and Corporate Communications

Mr. Chapman is our Senior Vice President, Investor Relations & Corporate Communications, having joined Poseida in February 2024. He has over 20 years’ experience spanning a broad range of strategic roles across the biotech sector. Prior to Poseida, he was the Head of Corporate Communications & Investor Relations at Atara Biotherapeutics, the first company in the world to receive regulatory approval for an allogeneic T-cell immunotherapy. Previously, Mr. Chapman held a series of global and U.S. leadership roles at Amgen, including Corporate Affairs, Value, Access & Pricing, and U.S. Business Operations. Earlier in his career he led multinational teams at U.S. and UK-based communications consultancies in support of a variety of biopharma companies.

Mr. Chapman began his career as a research scientist and holds a B.S.degree (honors) in Biochemistry and Molecular Biology from University College London.